![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
European Organisation for Research and Treatment of Cancer 50th Anniversary Conference: 50 Years of Progress Against Cancer
Brussels, Belgium, 15–16 March 2012
The European Organisation for Research and Treatment of Cancer (EORTC) 50th Anniversary Conference was held on the 15–16 March in Brussels, Belgium. More than 1100 participants (including EORTC members and staff, national research organizations, health authorities, patient advocacy groups, European Commission, cancer leagues and the pharmaceutical industry) registered for this conference that offered a unique opportunity to gather all the partners involved in the EORTC mission. The EORTC has been a pioneer in promoting multidisciplinary cancer research in a pan-European setting with a mission to improve the standard of cancer treatment for patients with cancer. This conference highlighted the tremendous progress that has been made over the past 50 years and pointed to the challenges that will be faced in the future.
Financial & competing interests disclosure
J Bean is medical science writer at the European Organisation for Research and Treatment of Cancer (EORTC). A Bottomley is the senior editor of the Expert Review of Pharmacoeconomics and Outcomes Research Editorial Board and assistant director of the EORTC. F Meunier is director general of the EORTC. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.